BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

387 related articles for article (PubMed ID: 19200057)

  • 1. Pathogenic perspectives for the role of inflammation in diabetic nephropathy.
    Rivero A; Mora C; Muros M; García J; Herrera H; Navarro-González JF
    Clin Sci (Lond); 2009 Mar; 116(6):479-92. PubMed ID: 19200057
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of TNF-alpha in diabetic nephropathy: pathogenic and therapeutic implications.
    Navarro JF; Mora-Fernández C
    Cytokine Growth Factor Rev; 2006 Dec; 17(6):441-50. PubMed ID: 17113815
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diabetes, inflammation, proinflammatory cytokines, and diabetic nephropathy.
    Navarro JF; Mora C
    ScientificWorldJournal; 2006 Aug; 6():908-17. PubMed ID: 16906324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of inflammatory cytokines in diabetic nephropathy.
    Navarro-González JF; Mora-Fernández C
    J Am Soc Nephrol; 2008 Mar; 19(3):433-42. PubMed ID: 18256353
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inflammation and the pathogenesis of diabetic nephropathy.
    Wada J; Makino H
    Clin Sci (Lond); 2013 Feb; 124(3):139-52. PubMed ID: 23075333
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammation and diabetic nephropathy.
    Mora C; Navarro JF
    Curr Diab Rep; 2006 Dec; 6(6):463-8. PubMed ID: 17118230
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor necrosis factor-alpha as a therapeutic target for diabetic nephropathy.
    Navarro-González JF; Jarque A; Muros M; Mora C; García J
    Cytokine Growth Factor Rev; 2009 Apr; 20(2):165-73. PubMed ID: 19251467
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relationship between oxidative stress and inflammatory cytokines in diabetic nephropathy.
    Elmarakby AA; Sullivan JC
    Cardiovasc Ther; 2012 Feb; 30(1):49-59. PubMed ID: 20718759
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Synergistic contributions of carbonyl stress and megsin in diabetic nephropathy.
    Inagi R; Nangaku M; Miyata T
    Ann N Y Acad Sci; 2005 Jun; 1043():605-8. PubMed ID: 16037283
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammatory pathways.
    Navarro-González JF; Mora-Fernández C
    Contrib Nephrol; 2011; 170():113-123. PubMed ID: 21659764
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diabetic nephropathy: where hemodynamics meets metabolism.
    Forbes JM; Fukami K; Cooper ME
    Exp Clin Endocrinol Diabetes; 2007 Feb; 115(2):69-84. PubMed ID: 17318765
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Diabetic nephropathy: from mechanisms to rational therapies.
    Giunti S; Barit D; Cooper ME
    Minerva Med; 2006 Jun; 97(3):241-62. PubMed ID: 16855519
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Diabetic microangiopathy: physiopathological, clinical and therapeutic aspects.
    Camera A; Hopps E; Caimi G
    Minerva Endocrinol; 2007 Sep; 32(3):209-29. PubMed ID: 17912158
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine and cytokine-like inflammation markers, endothelial dysfunction, and imbalanced coagulation in development of diabetes and its complications.
    Goldberg RB
    J Clin Endocrinol Metab; 2009 Sep; 94(9):3171-82. PubMed ID: 19509100
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Endothelial dysfunction and diabetes: possible role in kidney damage].
    Tesauro M; Leo R; Lauro R; Cardillo C
    G Ital Nefrol; 2009; 26 Suppl 46():62-70. PubMed ID: 19644821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Recent advancement of understanding pathogenesis of type 1 diabetes and potential relevance to diabetic nephropathy.
    Ichinose K; Kawasaki E; Eguchi K
    Am J Nephrol; 2007; 27(6):554-64. PubMed ID: 17823503
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammation in Diabetic Kidney Disease.
    Pérez-Morales RE; Del Pino MD; Valdivielso JM; Ortiz A; Mora-Fernández C; Navarro-González JF
    Nephron; 2019; 143(1):12-16. PubMed ID: 30273931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The contribution of hypertension to diabetic nephropathy and retinopathy: the role of inflammation and oxidative stress.
    Lopes de Faria JB; Silva KC; Lopes de Faria JM
    Hypertens Res; 2011 Apr; 34(4):413-22. PubMed ID: 21228783
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leukocyte recruitment and vascular injury in diabetic nephropathy.
    Galkina E; Ley K
    J Am Soc Nephrol; 2006 Feb; 17(2):368-77. PubMed ID: 16394109
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Diabetic nephropathy and prevention of diabetic nephropathy caused chronic renal insufficiency].
    Jakić M; Jakić M; Zibar L; Mihaljević D; Stipanić S; Teskera T
    Lijec Vjesn; 2009; 131(7-8):218-25. PubMed ID: 19769285
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.